A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bennett Chin, MD
Duke University
Principal Investigator - Camillo Jimenez, MD
MD Anderson Cancer
Principal Investigator - Daniel Pryma, MD
University of Pennsylvania
Principal Investigator - Jeffrey Olsen, MD
Mallinckrodt Institute of Radiology Washington University
Principal Investigator - Joseph Dillon, MD
University of Iowa
Principal Investigator - Lale Kostakoglu, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - Lilja Solnes, MD
Johns Hopkins University
Principal Investigator - Michael H Pampaloni, MD
University of California at San Francisco
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California-San Francisco
San Francisco, California, United States
- University of Miami Miller School of Medicine
Miami, Florida, United States
- University of Iowa
Iowa City, Iowa, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Washington University School of Medicine, Alvin J. Siteman Cancer Center
St Louis, Missouri, United States
- Mount Sinai School of Medicine
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jun 2009
- Primary completion
- 14 Feb 2017
- Completion
- 28 Feb 2021
- Last update posted
- 20 Feb 2020
- Registered enrollment
- 74
- Registry id
- NCT00874614
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.